Спайдер торгуется на премаркете ниже ключевого уровня 155.00.
Европейские индексы на отрицательной территории.
Nikkei +1,6 %, Shanghai - закрыт.
SPY (внутридневной график) падение на премаркете. Сопротивление 155.25. Поддержка: 154.75
Ожидаемая макроэкономическая статистика:
Fed's Yellen speaks (5pm)
March Nonfarm Payrolls (8:30am)- Briefing.com consensus 192K
March Nonfarm Private Payrolls (8:30am)- Briefing.com consensus 210K
March Unemployment Rate (8:30am)- Briefing.com consensus 7.7%
March Hourly Earnings (8:30am)- Briefing.com consensus +0.2%
March Average Workweek (8:30am)- Briefing.com consensus 34.5
February Trade Balance (8:30am)- Briefing.com consensus -$44.7 bln
February Consumer Credit (8:30am)- Briefing.com consensus $14 bln
Премаркет NYSE/NASDAQ:
Gapping up
In reaction to strong earnings/guidance: WDFC +7.5%, XRTX +1.9%, HBI +1.8%.
Other news: XIDE +24.1% (modestly rebounding, confirmed it has retained financial advisor; sees Q4 free cash flow of ~$50 mln vs prior guidance of $30 mln), NIHD +7.9% (announces sale of Nextel Peru to Entel for $400 mln), MAKO +4.8% (MAKO Surgical secures court-ordered permanent injunction against Blue Belt Technologies), VLO +3.8% (Board approves spin-off of CST Brand), APP +2.9% ( closes private offering of $206 mln principal amount of its 13% senior secured notes due 2020; enters into a new $35 mln five-year asset-backed revolving credit facility with Capital One Bank), ATRS +1.7% (announces notice of allowance for new patent on VIBEX QuickShot Device).
Analyst comments: BBG +1.8% (ticking higher, upgraded to Buy from Neutral at Goldman), CELG +0.9% (upgraded to Buy from Hold at Deutsche Bank), MBT +0.3% (upgraded to Overweight from Neutral at JP Morgan)
Gapping down
In reaction to disappointing earnings/guidance: FFIV -17.1% (also multiple analyst downgrades and tgt cuts), RDWR -17%.
Financial related names showing weakness: NBG -9%, BCS -2.6%, ING -2.6%, HBC -1.5%, C -1.2%, DB -1.1%, BAC -0.9%, .
Select oil/gas related names showing early weakness: PTR -1.9%, RIG -1.4%, E -1.2%, SDRL -0.8%, RDS.A -0.8% (Royal Dutch Shell to sign Russian Artic drilling deal, according to reports), BP -0.7%, TOT -0.6%, STO -0.5%.
Several FFIV/RDWR related names are under pressure: JNPR -5.6%, CTXS -3.6%, CSCO -3.3%, VMW -2.5%, RAX -2.3%, CRM -1.9%, XLNX -1%,
Other news: RIGL -29.6% (AstraZeneca reports top-line results from OSKIRA-1 Phase 3 study of Fostamatinib in Rheumatoid Arthritis, Rigel Pharma downgraded to Market Perform from Outperform at BMO Capital Mkts), SABA -12% (announced anticipated delisting from NASDAQ global select market; disclosed SEC investigation), ETP -3.5% (announces 12 mln common unit offering), SAP -2.5% and DEO -1.7% (still checking), BDN -1.1% (announces offering of 10 mln common shares), UL -0.9% (still checking), LVS -0.5% (Las Vegas Sands CEO Sheldon Adelson says Richard Suen did not help co get Macau license, according to reports).
Analyst comments: KMB -0.6% (downgraded to Underperform from Market Perform at BMO Capital)
Торговые идеи NYSEи NASDAQ:
NIHD – компания анонсировала продажу подразделение Nextel Peru за 400 млн долларов. Акции слабее рынка. Ключевые уровни – 4.50 и 5.00. Работаем исходя из цены открытия.
VLO – совет директоров одобрил Spin off CST Brands. Смотрим акцию в лонг выше 43.00. Ориентируемся на уровень 43.50.
CSCO – компания торгуется на премаркете ниже вчерашнего закрытия. Причина – реакция на conference call F5 Networks (FFIV). Выше 20.50 смотрим акцию в лонг с потенциалом в 50 центов. Другие компании отреагировавшие аналогично: JNPR(лонг выше 17.25, шорт ниже 17.00), CRM, CTXS, VMW.
ETP– дополнительное размещение 12 млн. акций. Ниже 48.00 смотрим акцию на шорт, выше 48.50 можно искать точку входа на лонг.
In reaction to strong earnings/guidance: GBX +3.2%.
Financial related names showing strength: ING +5% (upgraded to Outperform from Neutral at Exane BNP Paribas ), RBS +4.3%, ING +3.6%, BBVA +2%, SAN +1.9%, DB +1.8% (derivatives portfolio is being probed by German regulators, according to reports ), BCS +1.3%, BAC +0.8%, JPM +0.7%, C +0.7%, HBC +0.3%.
Select metals/mining stocks ticking higher: VALE +2.1%, MT +1.8%, RIO +1.5% (Some RIO mines may be purchased by Coal India, according to reports), BBL +1.3%, BHP +0.9%.
Select Japan related names ticking higher after the BOJ has announced a open-ended bond purchase plan: SMFG +5.2%, NMR +5.1%, TM +3.5%, MTU +3.4%, HMC +3%.
A few telcom names are higher: TEF +2.4%, TI +2.1%, FTE +1.1%
Other news: NAVB +6.7% (Navidea Biopharmaceuticals reports positive top-line results from interim analysis of Lymphoseek Phase 3 clinical trial in head and neck cancer), RDY +3.2% (light volume, Dr. Reddy's launches Zoledronic Acid Injection), FB +0.6% (ahead of expected Android launch), .
Analyst comments: NKA +6.9% (light volume, upgraded to Outperform from Market Perform at Wells Fargo, upgraded to Equal Weight from Underweight at Barclays), PT +6.3% (added to Conviction Buy at Goldman), PANL +3.1% (upgraded to Buy at Needham), FNSR +3.1% (upgraded to Buy from Neutral at Lazard), SRPT +2.8% (initiated with Outperform at Baird), PNRA +2.1% (added to Conviction Buy list at Goldman), TMH +1.8% (added to Conviction Buy list and upgraded from Neutral at Goldman ), BRO +1.5% (ticking higher, upgraded to Neutral from Sell at Goldman), EAT +0.8% (upgraded to Buy from Neutral at Goldman), AAPL +0.4% (initiated with a Buy at Lazard)
Gapping down
In reaction to disappointing earnings/guidance: CPWR -2.7%, MIND -2.5%, LULU -1.5%.
A few European drug names are lower: NVS -1.3%, AZN -1.1%
Other news: MACK -7.4% (announces top-line results from a single arm Phase 2 advanced lung cancer study in patients with resistance to an anti-EGFR tyrosine kinase inhibitor -- one cohort of a Phase 2 non-small cell lung cancer study did not meet its primary endpoint), LSE -2.4% (announced the commencement of a public offering of 6,500,000 shares of its common stock), STM -2.2% and ARMH -1.9% (still checking), CCL -1.9% (continued weakness on Triumph news), DEO -1.4% (still checking), RDS.A -0.6% (Royal Dutch Shell Geelong Australia refinery is now for sale, according to reports ).
Analyst comments: LCC -1.8% (downgraded to Neutral from Buy at BofA/Merrill), ARUN -1.8% (downgraded to Neutral from Buy at UBS), AVA -1% (ticking lower, downgraded to Neutral from Buy at UBS), MSFT -0.6% (downgraded to Neutral from Buy at BofA/Merrill)
Торговые идеи NYSEи NASDAQ:
CPWR – компания понизила прогноз по EPS и выручке на 4 квартал. Лонг выше 11.75, ниже 11.50 смотрим акцию в шорт с потенциалом от 25 до 50 центов.
CCL – компания из индекса SP500. На премаркете небольшой гэп вниз, ниже 32.75 смотрим акцию в шорт.
GBX – смешанный отчет, ожидают FY13 таким же как FY12. Премаркет малоактивный, но на открытии возможна хорошая волатильность. Ключевой уровень – вчерашний максимум 23.00 и минимум 21.50.
Спайдер торгуется на премаркете с незначительным понижением.
Европейские индексы на отрицательной территории.
Nikkei +3.0 %, Shanghai около нулевой отметки.
SPY (внутридневной график) рост на премаркете. Сопротивление 157.00. Поддержка: 156.60
Ожидаемая макроэкономическая статистика:
MBA Mortgage Index (7am)- Prior +7.7%
March ADP Employment Change (8:15am)- Briefing.com consensus 197K
March ISM Services (10am)- Briefing.com consensus 55.5, February 56.0
Petroleum Inventories (10:30am)
Премаркет NYSE/NASDAQ:
Gapping up
In reaction to strong earnings/guidance: CALL +15.1%, MON +1.9%, GIII +1.7%.
M&A news: OMPI +11.5% (Obagi Medical and Valeant Pharmaceuticals agree on an increased offer price of $24.00 per share in cash).
Other news: ZNGA +10.7% (announces ZyngaPlusPoker and ZyngaPlusCasino launching for UK players; co's first real money games), NVAX +8.5% (reports positive top-line results from Phase 2 clinical trial of RSV vaccine candidate in women of childbearing age), MHR +7.6% (Penn Virginia enters into a definitive agreement with Magnum Hunter Resources (MHR) to acquire producing properties and undeveloped leasehold interests in the Eagle Ford Shale play for ~ $400 mln), GLUU +7.3% (higher with ZNGA), NFX +7.2% ( announces 'significant' discovery offshore Malaysia, provides update on process to explore strategic alternatives for international businesses), ZOLT +5.9% ( announces review of its strategic alternatives), BUD +1.7% and NVO +1.6% (still checking), FB +1.1% (SEC says social media OK for company announcements if investors are alerted), CSCO +0.2% (announces intent to acquire Ubiquisys, a provider of 3G and long-term evolution small cell technology for approx $310 mln in cash and retention-based incentives).
Analyst comments: ALXA +7.1% (upgraded to Overweight from Neutral at Piper Jaffray), SIX +0.9% (added to Conviction Buy List at Goldman), NEE +0.9% ( added to Conviction Buy List at Goldman), NKE +0.8% (tgt to $67 from $56 at HSBC), CMG +0.7% (upgraded to Mkt Perform from Underperform at Raymond James)
Gapping down
In reaction to disappointing earnings/guidance: GPN -6.4%, ATML -3% (also appoints Steve Skaggs as interim Chief Financial Officer), CAG -2.1%
A few financial related names showing weakness: NBG -5.5%, ING -1.8%, SAN -1.3%, RBS -1.3%, BBVA -1.1%.
Select metals/mining stocks trading lower: GFI -2.9% (downgraded to Neutral from Outperform at Credit Suisse), HMY -2%, BHP -1.1%, BBL -0.8%, MT -0.7%, AU -0.7% (AngloGold downgraded to Neutral from Outperform at Credit Suisse).
A few telecom names trading lower: VOD -3.5% (Verizon discloses it is a willing purchaser of the 45% stake Vodafone holds in Verizon, but does not have any intention to merger with or make an offer for Vodafone), FTE -2.9%, PT -2.2%
Other news: TTM -4.8% (light volume, still checking), SEP -3.7% (commenced an underwritten public offering of 4,500,000 of its common units representing limited partner interests), ARCC -2.8% (announces public offering of 16.65 mln shares of common stock), TSLA -2.6% (announces new finance product in partnership with Wells Fargo (WFC) and US Bank ), LCC -0.9% (reports record March Load Factor of 86.1%, up 1.5 points YoY; PRASM results are lower than previous guidance), CHFN -0.4% (announces results of Stock Offering, Stockholder Vote and Member Vote).
Analyst comments: ADT -1.7% (downgraded to Underweight from Equal-Weight at Morgan Stanley),CRL -2.6% (ticking lower, downgraded to Sell from Neutral at Citigroup), CNS -2.1% (downgraded to Underperform from Buy at BofA), LM -1.4%
Торговые идеи NYSEи NASDAQ:
NFX– компания сообщила об открытии месторождения газа в Малайзии. Технически – очень слабая акция. Смотрим в шорт от уровней предыдущего пика – 24.00-24.20
TSLA – производитель автомобилей сообщил о новом партнерском соглашении (лизинг и кредитные программы) с Wells Fargo. Акция торгуется достаточно высоко, при закреплении выше 44.00 смотрим акцию в лонг.
CAG – отчет хуже ожидание аналитиков по EPS и выручке, подтверждение прогноза по EPS на FY13. Выше 34.00 смотрим акцию в лонг, потенциал движения 25-50 центов.
Спайдер торгуется на премаркете у локального уровня сопротивления.
Европейские индексы на положительной территории.
Nikkei -1.1%, Shanghai около нулевой отметки.
SPY (внутридневной график) рост на премаркете. Сопротивление 156.9. Поддержка: 155.75 – 156.00
Ожидаемая макроэкономическая статистика:
Mar ISM - NY (8:45am)
Feb Factory Orders (9am)
Kocherlakota Speaks on Monetary Policy in North Dakota (12pm)
Lockhart Speaks in Alabama (12:30pm)
Fed's Evans, Lacker Speak on Monetary Policy in Richmond (6:30pm)
Премаркет NYSE/NASDAQ:
Gapping up
In reaction to strong earnings/guidance: WYY +13.8% (thinly traded), URBN +4.4%.
M&A news: OMPI +15.7% (Merz Pharma Group makes superior proposal to acquire Obagi Medical Products for $22/share in cash), VOD +5.2% (AT&T and Verizon may be considering bid for VOD, according to reports).
Select financial related names showing strength: MTU +3.6%, CS +2.8%, DB +2.3%, UBS +2.2%, BCS +2.0%, ING +1.8%, HBC +1.4%.
Select healthcare related names showing strength: UAM +9.4%, HUM +9.3% (expects its 2014 Medicare Advantage bid benchmark premium to include an increase for medical cost trend of ~3.4% vs. the previously expected reduction of ~2.2%), UNH +3.4%, CI +3.1%, MOH +2.4%, AET +2.1%, HCA +1.2%, CVH +1%, WCG +0.9%, AGP +0.3%, .
Other news: BGCP +40.3% (BGC announces sale of its platform for the fully electronic trading of benchmark, on-the-Run U.S. Treasuries to NASDAQ OMX), BCRX +8.7% (Bird Flu deaths in China have generated a WHO probe, according to reports), NUAN +6.5% (Carl Icahn earlier disclosed 9.27% passive stake in 13G filing), HTZ +4.1% (discloses investor update in slide presentation), SWY +3.1% (trading higher following positive MadMoney mention), ACT +2.7% (confirms favorable ruling in generic Pulmicort RESPULES patent suit), SVU +2.5% ( S.A.C. Capital discloses 5.1% passive stake in 13G filing ), TTM +2.5% (Tata Motors March India sales fell 28% YoY, according to reports), UN +1.7% (still checking), NFLX +1.3% (trading higher following positive MadMoney mention), ARNA +1.1% (discloses U.S. District Court granted motions to dismiss stockholder actions), SAP +1% (still checking), BP +0.9% (BP spill administrator wants lawsuit dismissed, according to reports ), AMZN +0.7% (hired former Windows phone exec Charlie Kindel, according to reports), C +0.5% (Citigroup $590 settlement is being questioned by a Judge, according to reports), WMC +0.5% (raises its quarterly dividend to $0.95; announces revisions to annual and quarterly results), FB +0.5% (is in discussions to acquire online dating company, Bang With Friends for $30 mln, according to reports).
Analyst comments: EHTH +8.6% (upgraded to Buy from Neutral at BofA/Merrill), MCP +2.9% (initiated with a Buy at DA Davidson), DVA +1.3% (upgraded to Buy from Hold at Deutsche Bank), AZN +1.2% (upgraded to Neutral from Underweight at JP Morgan), QCOM +1.2% ( upgraded to Strong Buy from Outperform at Raymond James)
Gapping down
In reaction to disappointing earnings/guidance: AFFY -4.4% (light volume), SCVL -2.8%.
Select metals/mining stocks trading lower: MT -2.5%, GFI -1.3%, AUY -0.7%, AU -0.6%, SLV -0.5%, NEM -0.4%.
Other news: NBG -12.1% (still checking, reports out this morning indicate that Cyprus finance minister Sarris resigns), NAT -12% (announced public offering of $87 mln aggregate amount of common shares), NDAQ -7.5% (BGC announces sale of its platform for the fully electronic trading of benchmark, on-the-Run U.S. Treasuries to NASDAQ OMX), ASMI -2.4% (still checking), IRET -2.1% (announces public offering of common shares of beneficial interest), TECD -0.8% (announced delay of filing annual report because it requires additional time to complete the required financial statements and restatement), PRE -0.7% (attributed to pricing of block trade).
Analyst comments: HPQ -4.0% (downgraded to Sell from Neutral at Goldman), GRPN -0.7% (initiated with a Sell at UBS), LLTC -0.7% (downgraded to Hold from Buy at Stifel), TXN -0.6% (downgraded to Hold from Buy at Stifel), RAX -0.5% (downgraded to Market Perform from Outperform at Wells Fargo)
Торговые идеи NYSEи NASDAQ:
BGCP- вчера компания анонсировала продажу своей платформы для электронной торговли облигациями США бирже NASDAQ OMX. Смотрим на оба тикера (BGCP и NDAQ). BGCP – смотрим цену открытия и уровень 5.50. Ниже него – продажа, выше – покупка. Потенциал 50 центов.
NUAN – Carl Icahn раскрыл приобретение 9,27% акций компании. Отталкиваемся от уровня 22.00, ниже него смотрим акцию на продажу. При закреплении выше и удержании бида возможен лонг.
URBN – форма 10К, CEO ожидает рост продаж в 1 квартале 2014. Продаем акцию ниже 40.00
CVH – движение на новостях сектора. Снижение затрат для фармацевтических компаний. Смотрим на поведение акции после 10.00 NY. Хорошая идея – торговля баскетом компаний сектора. (HNT, HUM, MOH, CNC, UAM, WLP, AET, CVH, CI, HUM, HCA, WCG, GTS, EMCI, AGP, MGLN).